PARV4: An Emerging Tetraparvovirus

PARV4 was first reported in 2005 in a hepatitis B virus–infected injecting drug user (IDU) [1]. It was detected by a screening process that aimed to identify new DNA viruses in subjects reporting risk factors for HIV combined with nonspecific symptoms of “viral infection syndrome”, including fatigue, malaise, and headache [1].

Source: www.plospathogens.org

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.